New Journey Health Hits Day Low of CNY 2.15 Amid Price Pressure

New Journey Health Technology Group Co., Ltd. experienced a significant decline today, with the stock dropping by 5.24% on March 23, 2026. The stock reached an intraday low of CNY 2.15, reflecting ongoing challenges within the company. Over the past week, New Journey Health has seen a notable decrease of 11.79%, while its performance over the last month shows a decline of 8.82%. Year-to-date, the stock has managed a slight gain of 1.88%, contrasting sharply with its one-year performance, which stands at a loss of 17.8%. The company operates within the Pharmaceuticals & Biotechnology sector and holds a market capitalization of CNY 7,718 million. Key financial metrics indicate a high debt-to-equity ratio of 0.78 and a return on equity of 1.27%. The stock's price-to-earnings ratio is notably high at 114.00, suggesting a premium valuation relative to its earnings. Overall, New Journey Health continues to face challenges, as evidenced by its consistent underperformance against the China Shanghai Composite index over the past three years.